MedTrace Logo

Effect of Perceptual Training and Phonetic Placement Therapy in Children With Cochlear Implant

NCT07613034 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2026-05-29

No results posted yet for this study

Summary

Background:

Children with cochlear implants often continue to exhibit speech sound and intelligibility difficulties despite improved auditory access. Perceptual training and phonetic placement therapy are commonly used interventions; however, limited evidence exists comparing their relative effectiveness in improving speech intelligibility in this population.

Objective:

To find the effect of perceptual training and phonetic placement therapy in children with cochlear implant.

Methods:

A randomized controlled trial was conducted involving 12 children with cochlear implants aged 6-8 years, with hearing ages ranging from 1-4 years. Participants were recruited using convenience sampling and randomly allocated into two intervention groups: Perceptual Training (n = 5) and Phonetic Placement Therapy (n = 6). Each participant received 12 hours of therapy over an 8-week period (three sessions per week, 30 minutes each). Speech outcomes were assessed pre-intervention, post-intervention, and after a two-week retention period using the Test of Articulation and Phonology Urdu (TAPU), Percent Consonants Correct (PCC), and a 5-point speech intelligibility rating scale scored by blinded listeners. Repeated-measures ANOVA was used for data analysis.

Key words Cochlear implant, children, speech sound disorder, speech intelligibility, phonetic, hearing, perceptual training

Conditions

  • Cochlear Implant
  • Children
  • Speech Sound Disorder

Interventions

OTHER

Phonetic placement therapy

Phonetic placement therapy to improve speech intelligibility for speech sound disorders

OTHER

perceptual training

Perceptual Training Therapy to improve speech intelligibility for speech sound disorders

Sponsors & Collaborators

  • SADA NGO

    collaborator UNKNOWN

  • Riphah International University

    lead OTHER

Principal Investigators

  • Nazia Mumtaz, PhD · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-20
Primary Completion
2025-12-20
Completion
2026-01-29

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07613034 on ClinicalTrials.gov